FEATURED

FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment

  • All
  • Education
  • Events
  • Press Releases
See more news
See more press releases

Social media

nspharmainc NS Pharma @nspharmainc ·
14h

#EGPA is a rare condition that can involve asthma, sinusitis, skin rashes and nerve pain, making diagnosis difficult. #NSPharma is working to change that with NS-229, now in phase 2 trials and offering new hope for patients.

Learn more: https://ow.ly/hQNf50XJwaj

#RareDiseases https://x.com/NSPharmaInc/status/2001306684833046816/photo/1

nspharmainc NS Pharma @nspharmainc ·
15 Dec

Welcome Dino Sirianni to #NSPharma as our new Key Account Manager!

He brings extensive experience from Amneal Biosciences, American Regent, Pfizer and EKR Therapeutics. In his spare time, he enjoys golf and family time.

#WelcomeToTheTeam #NewHire https://x.com/NSPharmaInc/status/2000582019848212856/photo/1

nspharmainc NS Pharma @nspharmainc ·
12 Dec

#EGPA is a rare immune disease that often starts with asthma and allergies. Current treatments rely on steroids, but #NSPharma is developing NS-229, a more targeted therapy now in clinical trials with FDA Orphan Drug status.

Learn more: https://ow.ly/sbGw50XIoHG

#RareDiseases https://x.com/NSPharmaInc/status/1999494554970464560/video/1

nspharmainc NS Pharma @nspharmainc ·
10 Dec

Dystrophin is a vital protein that protects muscles as they contract and relax.

#Duchenne muscular dystrophy occurs when the body can't make usable dystrophin, causing muscles to weaken over time and affecting the heart and lungs.

Learn more: https://ow.ly/VT7V50XGNRE

#DMD https://x.com/NSPharmaInc/status/1998770178100748364/photo/1

nspharmainc NS Pharma @nspharmainc ·
8 Dec

Say hello to Kellie Drangeid, our newest Area Business Manager!

With 20+ years in strategic account management, reimbursement and field leadership across neurology, immunology and rare disease, she brings incredible expertise to the #NSPharma team!

#RareDisease #NewHire https://x.com/NSPharmaInc/status/1998045261529006280/photo/1

nspharmainc NS Pharma @nspharmainc ·
5 Dec

We’re excited to connect with the #Duchenne community in Phoenix at the upcoming #CureDuchenne Community Dinner!

Join families, caregivers & advocates for an evening of shared experiences and support.

📅 Dec 6
🕒 6–9 PM

Reserve your seat: https://ow.ly/T9VV50XCHaV

#NSPharma https://x.com/NSPharmaInc/status/1996958159319998839/photo/1

nspharmainc NS Pharma @nspharmainc ·
3 Dec

On International Day of Persons with Disabilities, we celebrate the strength and resilience of individuals living with disabilities.

At NS Pharma, we’re committed to advancing access, inclusion, and innovation so every person has the opportunity to thrive.

#InclusionMatters https://x.com/NSPharmaInc/status/1996233403524333722/photo/1